Growth cap on UK’s health service branded drugs bill will rise to 4% from 2027
NHS agrees new drug sales deal with global pharmaceutical groups
Recent Posts
- Pomp prevails over substance as Trump hosts Xi
- Private equity could revolutionise US lawyer pay, law firm bosses say
- Republicans spend big to counter Trump’s sinking popularity
- Goldman reaped more than $200mn in fees from hedge fund Situational Awareness
- The AI agent revolution has moved a big step closer
